PhotoCure ASA is a Norwegian pharmaceutical company listed on the Oslo
Stock Exchange. The company develops and sells pharmaceuticals and medical
devices for the treatment and diagnosis of different types of cancer. The
products are based on proprietary photodynamic technologies, targeting
specific dermatology and oncology markets.
Through worldwide studies, PhotoCure is developing its technology for new
indications, such as acne, colon cancer and cervical cancer. The aim is to
create a broad pipeline of follow-on products and technologies. PhotoCure is
also developing photochemical internalization (PCI), a technology for
light-directed drug delivery through its subsidiary PCI Biotech AS.